Regarding the experimental animal studies of PDAC, CD44 was among the stemness markers successfully applied in the classic study by Li et al. [16] to identify the fraction of carcinoma cells, featuring high tumorigenicity in a mouse model along with self-renewal capabilities and the ability to produce phenotypically diverse cancer cells. This evidence concerns the gene CD44 and carcinoma.